ITIF:2025年“大型制药公司”是一个正常的行业报告(英文版).pdf |
下载文档 |
资源简介
Many right and left-wing populists argue that U.S. drug profits are excessive, that drug prices are driving up health-care costs, and that drug companies spend too little on developing new drugs. All three claims are wrong. When adjusting for risk and comparing it to other industries, pharmaceutical firms’ profits are not excessive, nor are drug prices driving up overall health-care expenditures. American consumers’ out-of-pocket expenditures on drugs over the past two decades have grown
已阅读到文档的结尾了